Results 151 to 160 of about 12,603 (200)

Evidence based treatment of schizophrenia: do we know enough [PDF]

, 2011
Khan, Faheem, Naqvi, Haider A
core   +1 more source

Antipsychotic dose and efficacy for acute schizophrenia spectrum disorders: an updated systematic review and dose-response meta-analysis. [PDF]

EClinicalMedicine
Furukawa Y, Lin X, Rodolico A, Tian J, Wu H, Schneider-Thoma J, Priller J, Davis JM, Leucht S, Siafis S.   +9 more
europepmc   +1 more source

Antipsychotic treatment patterns and cardiometabolic medicine use: current real-world evidence. [PDF]

Epidemiol Psychiatr Sci
Radha Krishnan RP, Zoega H, Buckley NA, Raubenheimer JE.   +3 more
europepmc   +1 more source

Antipsychotics lower peripheral markers of inflammation in drug-naïve early psychosis: a pilot study. [PDF]

Front Psychiatry
Šafářová N, Kolenič M, Tašková I, Čapek V, Fürstová P, Španiel F.   +5 more
europepmc   +1 more source

Association of Antipsychotic Dose with Surrogate Efficacy and Safety Outcomes in Hospitalized Older Adults: A Retrospective Cohort Study. [PDF]

Drugs Aging
Sarisky NM, Clark CM, Seyse S, Cieri-Hutcherson NE, Woodruff AE.   +4 more
europepmc   +1 more source

Association between ABCDE bundle compliance and long-term outcomes: a secondary longitudinal analysis. [PDF]

Intensive Care Med
Boehm LM, Mart MF, LaNoue M, Siao SF, Pun BT, Bowton DL, Exline MC, Gong MN, Hite RD, Hough CL, Hyzy RC, Khan BA, Owens RL, Pisani MA, Rock P, Schmidt GA, Jackson JC, Ely EW, Girard TD, Brummel NE.   +19 more
europepmc   +1 more source

The efficacy and safety of pharmacological treatment for major depressive episode with mixed features specifier: a systematic review and meta-analysis. [PDF]

Psychol Med
Gao S, Chen Y, Liu J, Zhang Q, Zhao X, Liu B, Zhang Y, Li L, Wang G.   +8 more
europepmc   +1 more source